文章核心观点 - 领先的证券法律事务所Bleichmar Fonti & Auld LLP对Elanco Animal Health Incorporated(纽交所代码:ELAN)进行调查,可能存在违反联邦证券法的行为 [1][2] - Elanco公司正在开发两种重要的动物治疗产品Zenrelia和Credelio Quattro,但FDA在2024年6月未能批准这两种药物,并且Zenrelia将带有安全性警示 [3] - 由于这一消息,Elanco股价在2024年6月27日下跌超过21%,从6月26日的17.97美元/股下跌至14.27美元/股 [4] 公司概况 - Elanco公司主要从事动物疾病治疗产品的开发 [3] - 公司正在开发的两种重要产品分别是Zenrelia(治疗犬类皮肤炎)和Credelio Quattro(广谱口服驱虫药,可治疗跳蚤、蜱和内部寄生虫) [3] 监管审批情况 - Elanco公司表示FDA拥有完成审查所需的所有数据,所有技术部分(包括标签)预计将在2024年6月底前获得批准 [3] - 但2024年6月27日,Elanco公司宣布FDA预计在2024年6月不会批准这两种药物,并且Zenrelia将带有安全性警示 [3] 股价影响 - 由于上述消息,Elanco股价在2024年6月27日下跌超过21%,从6月26日的17.97美元/股下跌至14.27美元/股 [4]

NEW YORK, July 27, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Elanco Animal Health Incorporated (NYSE:ELAN) for potential violations of the federal securities laws. If you invested in Elanco, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elanco-animal-health-incorporated. Why Did Elanco’s Stock Drop? Elanco develops products to treat diseases in animals. Two of the most importa ...

Shares of Elanco Animal Health (ELAN) have declined 6.1% since Jul 9, following the completion of the divestiture of its aqua business to Merck Animal Health, a subsidiary of Merck & Co.  (MRK) , for approximately $1.3 billion in cash. Although its shares are down, Elanco is focused on the long-term positive strategic move that will enable the company to concentrate on high-value opportunities in pet health and livestock sustainability while enhancing its financial flexibility.The company plans to use the n ...

NEW YORK, July 22, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Elanco Animal Health Incorporated (NYSE:ELAN) for potential violations of the federal securities laws. If you invested in Elanco, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elanco-animal-health-incorporated. Why Did Elanco’s Stock Drop? Elanco develops products to treat diseases in animals. Two of the most importa ...

NEW YORK, July 20, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Elanco Animal Health Incorporated (NYSE:ELAN) for potential violations of the federal securities laws. If you invested in Elanco, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elanco-animal-health-incorporated. Why Did Elanco’s Stock Drop? Elanco develops products to treat diseases in animals. Two of the most importa ...

GREENFIELD, Ind., July 18, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its second quarter 2024 financial results on Thursday, August 8, 2024. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company's performance. The conference call will begin at 8:00 a.m. eastern time. Investors, media, and the general public can access a live webcast of the conference call through the link that will be posted on Elan ...

NEW YORK, July 16, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Elanco Animal Health Incorporated (NYSE:ELAN) for potential violations of the federal securities laws. If you invested in Elanco, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elanco-animal-health-incorporated. Why Did Elanco's Stock Drop? Elanco develops products to treat diseases in animals. Two of the most importa ...

NEW YORK, July 16, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Elanco Animal Health Incorporated (NYSE:ELAN) for potential violations of the federal securities laws. If you invested in Elanco, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elanco-animal-health-incorporated. Why Did Elanco’s Stock Drop? Elanco develops products to treat diseases in animals. Two of the most importa ...

SAN FRANCISCO, July 15, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Elanco Animal Health Incorporated (NYSE: ELAN) investors who suffered substantial losses to submit your losses now. Visit: www.hbsslaw.com/investor-fraud/elan Contact the Firm Now: ELAN@hbsslaw.com                                       844-916-0895 Investigation into Elanco Animal Health Incorporated (ELAN): Elanco Animal Health is facing questions from investors regarding the accuracy of its previous statements concerning the commercial l ...

NEW YORK, July 13, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Elanco Animal Health Incorporated (NYSE:ELAN) for potential violations of the federal securities laws. If you invested in Elanco, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elanco-animal-health-incorporated. Why Did Elanco’s Stock Drop? Elanco develops products to treat diseases in animals. Two of the most importa ...